Mylan Estradiol Patch Shortage (2026): What Women on HRT Can Do Right Now
Mylan (Viatris) estradiol patches are currently backordered nationwide. The safest and most common solution is switching to another transdermal form—like gel or spray—which maintains the same safety profile. Most providers can transition you within 24–48 hours without...
TRICARE Testosterone Coverage: What Actually Gets Approved and What Gets Denied First
TRICARE covers testosterone therapy when hypogonadism is confirmed with lab results and proper documentation. Most denials happen before approval—not because TRT is excluded, but because referrals, lab timing, or prior authorization steps are incomplete. Medically...
Kaiser Hormone Therapy Coverage: How Referrals, Formularies, and Internal Rules Affect Access
Kaiser Permanente covers hormone therapy, but access depends heavily on internal referrals, formulary rules, and its closed-network system. Most delays happen before prescriptions are even approved—often at the referral or internal review stage rather than at the...
Anthem GLP-1 Coverage Guide: Prior Authorization, Step Therapy, and Exclusions
Anthem covers GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro, but approval is not automatic. Prior authorization is always required, and many plans include step therapy and employer-level exclusions that can block coverage—even when the medication is...